Skip to content
Catalyst

PapersPMID:40647178

Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial.

Nutrients2025The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidenceno difference foundHDL cholesterol
  2. Finding, moderate evidenceno difference foundGlycated haemoglobin (HbA1c)
Study, every finding
crossover · 4 weeks
Dose studied, every finding
45 g of walnut kernels per day
Population, every finding
Middle-aged adults (40-65 years) with at least one altered metabolic syndrome parameter and no medication; 28-day walnut period against a 28-day nut-free normocaloric control period, weight-maintenance diet advice in both

No finding here moved its endpoint.

Study record

Design
crossover trial
Species
human
Population
Middle-aged adults (Cluj-Napoca, Romania) with at least one altered metabolic syndrome parameter and no medication; whole walnut kernels (Juglans regia) 45 g/day vs a diet without walnuts
Participants
20
Comparator
no treatment
Duration
28 days
Endpoints measured
13